img

Global and India Weight-loss Drugs Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and India Weight-loss Drugs Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and India Weight-loss Drugs Market
This report focuses on global and India Weight-loss Drugs market, also covers the segmentation data of other regions in regional level and county level.
The global Weight-loss Drugs revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period (2024-2034).
In India the Weight-loss Drugs revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Weight-loss Drugs include Novo Nordisk, Currax, Ultimate life ltd, Wolfson Berg Ltd, Swiss Research Labs Ltd., Roar Ambition, Health and Nutrition Ltd., Abbott and Kellogg Company, etc. The global five biggest players hold a share of % in 2024.
Global Weight-loss Drugs Scope and Market Size
Weight-loss Drugs market is segmented in regional and country, by players, by type and by sales channels. Companies, stakeholders, and other participants in the global Weight-loss Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by sales channels for the period 2018-2034.
For India market, this report focuses on the Weight-loss Drugs market size by players, by Type and by Sales Channels, for the period 2018-2034. The key players include the global and local players, which play important roles in India.



By Company


Novo Nordisk
Currax
Ultimate life ltd
Wolfson Berg Ltd
Swiss Research Labs Ltd.
Roar Ambition
Health and Nutrition Ltd.
Abbott
Kellogg Company
Glanbia PLC
Ajinomoto Co. Inc.
Kraft Heinz Company
GlaxoSmithKline PLC
Herbalife Nutrition Ltd.
PepsiCo
Nestle
Amway Corp.
Segment by Type
Liquid
Powder
Softgels
Pills
Others
Segment by Sales Channels
Online Sales
Hospitals and Clinics
Pharmacy
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Weight-loss Drugs definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by sales channels, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Weight-loss Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Weight-loss Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by sales channels and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by sales channels and by region, sales, and revenue for each segment.
Chapter 8China by type, by sales channels, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by sales channels and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Weight-loss Drugs sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Weight-loss Drugs Product Introduction
1.2 Global Weight-loss Drugs Outlook 2018 VS 2024 VS 2034
1.2.1 Global Weight-loss Drugs Sales in US$ Million for the Year 2018-2034
1.2.2 Global Weight-loss Drugs Sales in Volume for the Year 2018-2034
1.3 India Weight-loss Drugs Outlook 2018 VS 2024 VS 2034
1.3.1 India Weight-loss Drugs Sales in US$ Million for the Year 2018-2034
1.3.2 India Weight-loss Drugs Sales in Volume for the Year 2018-2034
1.4 Weight-loss Drugs Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of India Weight-loss Drugs in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Weight-loss Drugs Market Size, India VS Global, 2018 VS 2024 VS 2034
1.5 Weight-loss Drugs Market Dynamics
1.5.1 Weight-loss Drugs Industry Trends
1.5.2 Weight-loss Drugs Market Drivers
1.5.3 Weight-loss Drugs Market Challenges
1.5.4 Weight-loss Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Weight-loss Drugs by Type
2.1 Weight-loss Drugs Market Segment by Type
2.1.1 Liquid
2.1.2 Powder
2.1.3 Softgels
2.1.4 Pills
2.1.5 Others
2.2 Global Weight-loss Drugs Market Size by Type
2.2.1 Global Weight-loss Drugs Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Weight-loss Drugs Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Weight-loss Drugs Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 India Weight-loss Drugs Market Size by Type
2.3.1 India Weight-loss Drugs Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 India Weight-loss Drugs Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 India Weight-loss Drugs Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Weight-loss Drugs by Sales Channels
3.1 Weight-loss Drugs Market Segment by Sales Channels
3.1.1 Online Sales
3.1.2 Hospitals and Clinics
3.1.3 Pharmacy
3.1.4 Others
3.2 Global Weight-loss Drugs Market Size by Sales Channels
3.2.1 Global Weight-loss Drugs Sales in Value, by Sales Channels (2018, 2024 & 2034)
3.2.2 Global Weight-loss Drugs Sales in Volume, by Sales Channels (2018, 2024 & 2034)
3.3.3 Global Weight-loss Drugs Average Selling Price (ASP) by Sales Channels (2018, 2024 & 2034)
3.3 India Weight-loss Drugs Market Size by Sales Channels
3.3.1 India Weight-loss Drugs Sales in Value, by Sales Channels (2018, 2024 & 2034)
3.3.2 India Weight-loss Drugs Sales in Volume, by Sales Channels (2018, 2024 & 2034)
3.3.3 India Weight-loss Drugs Average Selling Price (ASP) by Sales Channels (2018, 2024 & 2034)
4 Global Weight-loss Drugs Competitor Landscape by Company
4.1 Global Weight-loss Drugs Market Size by Company
4.1.1 Global Key Manufacturers of Weight-loss Drugs, Ranked by Revenue (2024)
4.1.2 Global Weight-loss Drugs Revenue by Manufacturer (2018-2023)
4.1.3 Global Weight-loss Drugs Sales by Manufacturer (2018-2023)
4.1.4 Global Weight-loss Drugs Price by Manufacturer (2018-2023)
4.2 Global Weight-loss Drugs Concentration Ratio (CR)
4.2.1 Weight-loss Drugs Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Weight-loss Drugs in 2024
4.2.3 Global Weight-loss Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Weight-loss Drugs, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Weight-loss Drugs, Product Offered and Application
4.5 Global Key Manufacturers of Weight-loss Drugs, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Weight-loss Drugs Market Size by Company
4.7.1 Key Players of Weight-loss Drugs in India, Ranked by Revenue (2024)
4.7.2 India Weight-loss Drugs Revenue by Players (2018-2023)
4.7.3 India Weight-loss Drugs Sales by Players (2018-2023)
5 Global Weight-loss Drugs Market Size by Region
5.1 Global Weight-loss Drugs Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Weight-loss Drugs Market Size in Volume by Region (2018-2034)
5.2.1 Global Weight-loss Drugs Sales in Volume by Region: 2018-2023
5.2.2 Global Weight-loss Drugs Sales in Volume Forecast by Region (2024-2034)
5.3 Global Weight-loss Drugs Market Size in Value by Region (2018-2034)
5.3.1 Global Weight-loss Drugs Sales in Value by Region: 2018-2023
5.3.2 Global Weight-loss Drugs Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Weight-loss Drugs Market Size YoY Growth 2018-2034
6.2 Americas Weight-loss Drugs Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Weight-loss Drugs Sales in Volume, by Sales Channels (2018, 2024 & 2034)
6.4 Americas Weight-loss Drugs Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Weight-loss Drugs Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Weight-loss Drugs Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Weight-loss Drugs Market Size YoY Growth 2018-2034
7.2 EMEA Weight-loss Drugs Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Weight-loss Drugs Sales in Volume, by Sales Channels (2018, 2024 & 2034)
7.4 EMEA Weight-loss Drugs Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Weight-loss Drugs Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Weight-loss Drugs Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Weight-loss Drugs Market Size YoY Growth 2018-2034
8.2 China Weight-loss Drugs Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Weight-loss Drugs Sales in Volume, by Sales Channels (2018, 2024 & 2034)
9 APAC
9.1 APAC Weight-loss Drugs Market Size YoY Growth 2018-2034
9.2 APAC Weight-loss Drugs Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Weight-loss Drugs Sales in Volume, by Sales Channels (2018, 2024 & 2034)
9.4 APAC Weight-loss Drugs Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Weight-loss Drugs Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Weight-loss Drugs Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Novo Nordisk
10.1.1 Novo Nordisk Company Information
10.1.2 Novo Nordisk Description and Business Overview
10.1.3 Novo Nordisk Weight-loss Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Novo Nordisk Weight-loss Drugs Products Offered
10.1.5 Novo Nordisk Recent Development
10.2 Currax
10.2.1 Currax Company Information
10.2.2 Currax Description and Business Overview
10.2.3 Currax Weight-loss Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Currax Weight-loss Drugs Products Offered
10.2.5 Currax Recent Development
10.3 Ultimate life ltd
10.3.1 Ultimate life ltd Company Information
10.3.2 Ultimate life ltd Description and Business Overview
10.3.3 Ultimate life ltd Weight-loss Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Ultimate life ltd Weight-loss Drugs Products Offered
10.3.5 Ultimate life ltd Recent Development
10.4 Wolfson Berg Ltd
10.4.1 Wolfson Berg Ltd Company Information
10.4.2 Wolfson Berg Ltd Description and Business Overview
10.4.3 Wolfson Berg Ltd Weight-loss Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Wolfson Berg Ltd Weight-loss Drugs Products Offered
10.4.5 Wolfson Berg Ltd Recent Development
10.5 Swiss Research Labs Ltd.
10.5.1 Swiss Research Labs Ltd. Company Information
10.5.2 Swiss Research Labs Ltd. Description and Business Overview
10.5.3 Swiss Research Labs Ltd. Weight-loss Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Swiss Research Labs Ltd. Weight-loss Drugs Products Offered
10.5.5 Swiss Research Labs Ltd. Recent Development
10.6 Roar Ambition
10.6.1 Roar Ambition Company Information
10.6.2 Roar Ambition Description and Business Overview
10.6.3 Roar Ambition Weight-loss Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Roar Ambition Weight-loss Drugs Products Offered
10.6.5 Roar Ambition Recent Development
10.7 Health and Nutrition Ltd.
10.7.1 Health and Nutrition Ltd. Company Information
10.7.2 Health and Nutrition Ltd. Description and Business Overview
10.7.3 Health and Nutrition Ltd. Weight-loss Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Health and Nutrition Ltd. Weight-loss Drugs Products Offered
10.7.5 Health and Nutrition Ltd. Recent Development
10.8 Abbott
10.8.1 Abbott Company Information
10.8.2 Abbott Description and Business Overview
10.8.3 Abbott Weight-loss Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Abbott Weight-loss Drugs Products Offered
10.8.5 Abbott Recent Development
10.9 Kellogg Company
10.9.1 Kellogg Company Company Information
10.9.2 Kellogg Company Description and Business Overview
10.9.3 Kellogg Company Weight-loss Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Kellogg Company Weight-loss Drugs Products Offered
10.9.5 Kellogg Company Recent Development
10.10 Glanbia PLC
10.10.1 Glanbia PLC Company Information
10.10.2 Glanbia PLC Description and Business Overview
10.10.3 Glanbia PLC Weight-loss Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Glanbia PLC Weight-loss Drugs Products Offered
10.10.5 Glanbia PLC Recent Development
10.11 Ajinomoto Co. Inc.
10.11.1 Ajinomoto Co. Inc. Company Information
10.11.2 Ajinomoto Co. Inc. Description and Business Overview
10.11.3 Ajinomoto Co. Inc. Weight-loss Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Ajinomoto Co. Inc. Weight-loss Drugs Products Offered
10.11.5 Ajinomoto Co. Inc. Recent Development
10.12 Kraft Heinz Company
10.12.1 Kraft Heinz Company Company Information
10.12.2 Kraft Heinz Company Description and Business Overview
10.12.3 Kraft Heinz Company Weight-loss Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Kraft Heinz Company Weight-loss Drugs Products Offered
10.12.5 Kraft Heinz Company Recent Development
10.13 GlaxoSmithKline PLC
10.13.1 GlaxoSmithKline PLC Company Information
10.13.2 GlaxoSmithKline PLC Description and Business Overview
10.13.3 GlaxoSmithKline PLC Weight-loss Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 GlaxoSmithKline PLC Weight-loss Drugs Products Offered
10.13.5 GlaxoSmithKline PLC Recent Development
10.14 Herbalife Nutrition Ltd.
10.14.1 Herbalife Nutrition Ltd. Company Information
10.14.2 Herbalife Nutrition Ltd. Description and Business Overview
10.14.3 Herbalife Nutrition Ltd. Weight-loss Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Herbalife Nutrition Ltd. Weight-loss Drugs Products Offered
10.14.5 Herbalife Nutrition Ltd. Recent Development
10.15 PepsiCo
10.15.1 PepsiCo Company Information
10.15.2 PepsiCo Description and Business Overview
10.15.3 PepsiCo Weight-loss Drugs Sales, Revenue and Gross Margin (2018-2023)
10.15.4 PepsiCo Weight-loss Drugs Products Offered
10.15.5 PepsiCo Recent Development
10.16 Nestle
10.16.1 Nestle Company Information
10.16.2 Nestle Description and Business Overview
10.16.3 Nestle Weight-loss Drugs Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Nestle Weight-loss Drugs Products Offered
10.16.5 Nestle Recent Development
10.17 Amway Corp.
10.17.1 Amway Corp. Company Information
10.17.2 Amway Corp. Description and Business Overview
10.17.3 Amway Corp. Weight-loss Drugs Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Amway Corp. Weight-loss Drugs Products Offered
10.17.5 Amway Corp. Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Weight-loss Drugs Industry Chain Analysis
11.2 Weight-loss Drugs Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Weight-loss Drugs Production Mode & Process
11.4 Weight-loss Drugs Sales and Marketing
11.4.1 Weight-loss Drugs Sales Channels
11.4.2 Weight-loss Drugs Distributors
11.5 Weight-loss Drugs Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Weight-loss Drugs CAGR in Value, India VS Global, 2018 VS 2024 VS 2034
Table 2. Weight-loss Drugs Market Trends
Table 3. Weight-loss Drugs Market Drivers
Table 4. Weight-loss Drugs Market Challenges
Table 5. Weight-loss Drugs Market Restraints
Table 6. Global Weight-loss Drugs Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India Weight-loss Drugs Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Weight-loss Drugs Sales Growth Rate (CAGR) by Sales Channels: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India Weight-loss Drugs Sales Growth Rate (CAGR) by Sales Channels: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Weight-loss Drugs, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Weight-loss Drugs Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Weight-loss Drugs Revenue Share by Manufacturer, 2018-2023
Table 13. Global Weight-loss Drugs Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Weight-loss Drugs Sales Share by Manufacturer, 2018-2023
Table 15. Global Weight-loss Drugs Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Weight-loss Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Weight-loss Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Weight-loss Drugs as of 2024)
Table 18. Global Key Manufacturers of Weight-loss Drugs, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Weight-loss Drugs, Product Offered and Application
Table 20. Global Key Manufacturers of Weight-loss Drugs, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Weight-loss Drugs in India, Ranked by Revenue (2024) & (US$ million)
Table 23. India Weight-loss Drugs Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Weight-loss Drugs Revenue Share by Players, (2018-2023)
Table 25. India Weight-loss Drugs Sales by Players, (K Units), (2018-2023)
Table 26. India Weight-loss Drugs Sales Share by Players, (2018-2023)
Table 27. Global Weight-loss Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Weight-loss Drugs Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Weight-loss Drugs Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Weight-loss Drugs Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Weight-loss Drugs Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Weight-loss Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Weight-loss Drugs Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Weight-loss Drugs Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Weight-loss Drugs Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Weight-loss Drugs Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Weight-loss Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Weight-loss Drugs Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Weight-loss Drugs Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Weight-loss Drugs Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Weight-loss Drugs Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Weight-loss Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Weight-loss Drugs Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Weight-loss Drugs Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Weight-loss Drugs Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Weight-loss Drugs Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Novo Nordisk Company Information
Table 48. Novo Nordisk Description and Business Overview
Table 49. Novo Nordisk Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Novo Nordisk Weight-loss Drugs Product
Table 51. Novo Nordisk Recent Development
Table 52. Currax Company Information
Table 53. Currax Description and Business Overview
Table 54. Currax Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. Currax Weight-loss Drugs Product
Table 56. Currax Recent Development
Table 57. Ultimate life ltd Company Information
Table 58. Ultimate life ltd Description and Business Overview
Table 59. Ultimate life ltd Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Ultimate life ltd Weight-loss Drugs Product
Table 61. Ultimate life ltd Recent Development
Table 62. Wolfson Berg Ltd Company Information
Table 63. Wolfson Berg Ltd Description and Business Overview
Table 64. Wolfson Berg Ltd Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Wolfson Berg Ltd Weight-loss Drugs Product
Table 66. Wolfson Berg Ltd Recent Development
Table 67. Swiss Research Labs Ltd. Company Information
Table 68. Swiss Research Labs Ltd. Description and Business Overview
Table 69. Swiss Research Labs Ltd. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Swiss Research Labs Ltd. Weight-loss Drugs Product
Table 71. Swiss Research Labs Ltd. Recent Development
Table 72. Roar Ambition Company Information
Table 73. Roar Ambition Description and Business Overview
Table 74. Roar Ambition Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. Roar Ambition Weight-loss Drugs Product
Table 76. Roar Ambition Recent Development
Table 77. Health and Nutrition Ltd. Company Information
Table 78. Health and Nutrition Ltd. Description and Business Overview
Table 79. Health and Nutrition Ltd. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Health and Nutrition Ltd. Weight-loss Drugs Product
Table 81. Health and Nutrition Ltd. Recent Development
Table 82. Abbott Company Information
Table 83. Abbott Description and Business Overview
Table 84. Abbott Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Abbott Weight-loss Drugs Product
Table 86. Abbott Recent Development
Table 87. Kellogg Company Company Information
Table 88. Kellogg Company Description and Business Overview
Table 89. Kellogg Company Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Kellogg Company Weight-loss Drugs Product
Table 91. Kellogg Company Recent Development
Table 92. Glanbia PLC Company Information
Table 93. Glanbia PLC Description and Business Overview
Table 94. Glanbia PLC Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Glanbia PLC Weight-loss Drugs Product
Table 96. Glanbia PLC Recent Development
Table 97. Ajinomoto Co. Inc. Company Information
Table 98. Ajinomoto Co. Inc. Description and Business Overview
Table 99. Ajinomoto Co. Inc. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Ajinomoto Co. Inc. Weight-loss Drugs Product
Table 101. Ajinomoto Co. Inc. Recent Development
Table 102. Kraft Heinz Company Company Information
Table 103. Kraft Heinz Company Description and Business Overview
Table 104. Kraft Heinz Company Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Kraft Heinz Company Weight-loss Drugs Product
Table 106. Kraft Heinz Company Recent Development
Table 107. GlaxoSmithKline PLC Company Information
Table 108. GlaxoSmithKline PLC Description and Business Overview
Table 109. GlaxoSmithKline PLC Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. GlaxoSmithKline PLC Weight-loss Drugs Product
Table 111. GlaxoSmithKline PLC Recent Development
Table 112. Herbalife Nutrition Ltd. Company Information
Table 113. Herbalife Nutrition Ltd. Description and Business Overview
Table 114. Herbalife Nutrition Ltd. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Herbalife Nutrition Ltd. Weight-loss Drugs Product
Table 116. Herbalife Nutrition Ltd. Recent Development
Table 117. PepsiCo Company Information
Table 118. PepsiCo Description and Business Overview
Table 119. PepsiCo Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. PepsiCo Weight-loss Drugs Product
Table 121. PepsiCo Recent Development
Table 122. Nestle Company Information
Table 123. Nestle Description and Business Overview
Table 124. Nestle Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Nestle Weight-loss Drugs Product
Table 126. Nestle Recent Development
Table 127. Amway Corp. Company Information
Table 128. Amway Corp. Description and Business Overview
Table 129. Amway Corp. Weight-loss Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Amway Corp. Weight-loss Drugs Product
Table 131. Amway Corp. Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Weight-loss Drugs Customers List
Table 135. Weight-loss Drugs Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Weight-loss Drugs Product Picture
Figure 2. Global Weight-loss Drugs Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Weight-loss Drugs Market Size 2018-2034 (US$ Million)
Figure 4. Global Weight-loss Drugs Sales 2018-2034 (K Units)
Figure 5. India Weight-loss Drugs Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. India Weight-loss Drugs Market Size 2018-2034 (US$ Million)
Figure 7. India Weight-loss Drugs Sales 2018-2034 (K Units)
Figure 8. India Weight-loss Drugs Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. India Weight-loss Drugs Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Weight-loss Drugs Report Years Considered
Figure 11. Product Picture of Liquid
Figure 12. Product Picture of Powder
Figure 13. Product Picture of Softgels
Figure 14. Product Picture of Pills
Figure 15. Product Picture of Others
Figure 16. Global Weight-loss Drugs Market Share by Type in 2024 & 2034
Figure 17. Global Weight-loss Drugs Sales in Value by Type (2018-2034) & (US$ Million)
Figure 18. Global Weight-loss Drugs Sales Market Share in Value by Type (2018-2034)
Figure 19. Global Weight-loss Drugs Sales by Type (2018-2034) & (K Units)
Figure 20. Global Weight-loss Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 21. Global Weight-loss Drugs Price by Type (2018-2034) & (US$/Unit)
Figure 22. India Weight-loss Drugs Market Share by Type in 2024 & 2034
Figure 23. India Weight-loss Drugs Sales in Value by Type (2018-2034) & (US$ Million)
Figure 24. India Weight-loss Drugs Sales Market Share in Value by Type (2018-2034)
Figure 25. India Weight-loss Drugs Sales by Type (2018-2034) & (K Units)
Figure 26. India Weight-loss Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 27. India Weight-loss Drugs Price by Type (2018-2034) & (US$/Unit)
Figure 28. Product Picture of Online Sales
Figure 29. Product Picture of Hospitals and Clinics
Figure 30. Product Picture of Pharmacy
Figure 31. Product Picture of Others
Figure 32. Global Weight-loss Drugs Market Share by Sales Channels in 2024 & 2034
Figure 33. Global Weight-loss Drugs Sales in Value by Sales Channels (2018-2034) & (US$ Million)
Figure 34. Global Weight-loss Drugs Sales Market Share in Value by Sales Channels (2018-2034)
Figure 35. Global Weight-loss Drugs Sales by Sales Channels (2018-2034) & (K Units)
Figure 36. Global Weight-loss Drugs Sales Market Share in Volume by Sales Channels (2018-2034)
Figure 37. Global Weight-loss Drugs Price by Sales Channels (2018-2034) & (US$/Unit)
Figure 38. India Weight-loss Drugs Market Share by Sales Channels in 2024 & 2034
Figure 39. India Weight-loss Drugs Sales in Value by Sales Channels (2018-2034) & (US$ Million)
Figure 40. India Weight-loss Drugs Sales Market Share in Value by Sales Channels (2018-2034)
Figure 41. India Weight-loss Drugs Sales by Sales Channels (2018-2034) & (K Units)
Figure 42. India Weight-loss Drugs Sales Market Share in Volume by Sales Channels (2018-2034)
Figure 43. India Weight-loss Drugs Price by Sales Channels (2018-2034) & (US$/Unit)
Figure 44. Americas Weight-loss Drugs Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 45. Americas Weight-loss Drugs Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 46. Americas Weight-loss Drugs Sales by Type (2018-2034) & (K Units)
Figure 47. Americas Weight-loss Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 48. Americas Weight-loss Drugs Sales by Sales Channels (2018-2034) & (K Units)
Figure 49. Americas Weight-loss Drugs Sales Market Share in Volume by Sales Channels (2018-2034)
Figure 50. United States Weight-loss Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 51. Canada Weight-loss Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 52. Mexico Weight-loss Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 53. Brazil Weight-loss Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 54. EMEA Weight-loss Drugs Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 55. EMEA Weight-loss Drugs Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 56. EMEA Weight-loss Drugs Sales by Type (2018-2034) & (K Units)
Figure 57. EMEA Weight-loss Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 58. EMEA Weight-loss Drugs Sales by Sales Channels (2018-2034) & (K Units)
Figure 59. EMEA Weight-loss Drugs Sales Market Share in Volume by Sales Channels (2018-2034)
Figure 60. Europe Weight-loss Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 61. Middle East Weight-loss Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 62. Africa Weight-loss Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 63. China Weight-loss Drugs Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 64. China Weight-loss Drugs Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 65. China Weight-loss Drugs Sales by Type (2018-2034) & (K Units)
Figure 66. China Weight-loss Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 67. China Weight-loss Drugs Sales by Sales Channels (2018-2034) & (K Units)
Figure 68. China Weight-loss Drugs Sales Market Share in Volume by Sales Channels (2018-2034)
Figure 69. APAC Weight-loss Drugs Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 70. APAC Weight-loss Drugs Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 71. APAC Weight-loss Drugs Sales by Type (2018-2034) & (K Units)
Figure 72. APAC Weight-loss Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 73. APAC Weight-loss Drugs Sales by Sales Channels (2018-2034) & (K Units)
Figure 74. APAC Weight-loss Drugs Sales Market Share in Volume by Sales Channels (2018-2034)
Figure 75. Japan Weight-loss Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. South Korea Weight-loss Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 77. China Taiwan Weight-loss Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 78. Southeast Asia Weight-loss Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 79. India Weight-loss Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 80. Weight-loss Drugs Value Chain
Figure 81. Weight-loss Drugs Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed